Bugao, Nida Z.

HRN: 00-10-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/28/2024
04/04/2024
IV
1.5g
Q6h
DM Foot
Waiting Final Action 
03/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/28/2024
04/14/2024
IV
600mg
Q8h
DM Foot
Waiting Final Action 
03/29/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/29/2024
04/15/2024
IV
4.5g
Q8h
Cellulitis, R Leg
Waiting Final Action 
04/02/2024
MUPIROCIN 2%, 15G (TUBE)
04/02/2024
04/09/2024
TOPICAL
15g
7 Days
Cellulitis
Waiting Final Action 
04/03/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/03/2024
04/09/2024
TOPICAL
Small Amount On Affected Area
BID
Infected Wound, Right Leg
Waiting Final Action 
04/04/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/04/2024
04/07/2024
TOPICAL
As Needef
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: